During the past decade, Richmond Pharmacology conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 10 clinical trials were completed, i.e. on average, 31.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 5 clinical trials were completed. i.e. 31.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Richmond Pharmacology" #1 sponsor was "Medicines for Malaria Venture" with 7 trials, followed by "Alnylam Pharmaceuticals" with 3 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Aegerion Pharmaceuticals, Inc." with 3 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Richmond Pharmacology" #1 collaborator was "Richmond Pharmacology Limited" with 13 trials as a collaborator, "PharmaKinetic Ltd" with 1 trials as a collaborator and "The Medicines Company" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Richmond Pharmacology" are "Malaria" (5 trials), "Healthy Volunteers" (4 trials), "Healthy" (3 trials), "Asthma" (2 trials) and "Healthy Volunteer" (2 trials). Many other conditions were trialed in "Richmond Pharmacology" in a lesser frequency.

Most popular intervention types in "Richmond Pharmacology" are "Drug" (40 trials), "Other" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Sterile Normal Saline (0.9% NaCl)" (3 trials), "Itraconazole" (2 trials), "Midazolam" (2 trials) and "RV521" (2 trials). Other intervention names were less common.

The vast majority of trials in "Richmond Pharmacology" are 34 trials for "All" genders, 4 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Richmond Pharmacology". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 30 completed trials in Richmond Pharmacology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Richmond Pharmacology, 33 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Richmond Pharmacology has several departments that took part in Clinical trials: "Richmond Pharmacology Ltd. 1a Newcomen St, London Bridge" - 3 trials